Anthony Letai was Named as the New Director of NIH's National Cancer Institute

Anthony Letai

Rare Cancer Day 2025: Illuminating the Hidden Frontiers of Oncology

Rare Cancer Day 2025

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Carlos Rodriguez-Galindo: GICC Progress Spotlighted at UNGA 80

Carlos Rodriguez-Galindo

Triple Combination of Encorafenib, Cetuximab, and Nivolumab in MSS BRAFV600E Metastatic Colorectal Cancer

nivolumab encorafenib cetuximab for brafv600e MSS CRC

Julie Gralow: Let’s Push for Dose Optimization for All Cancer Treatments

Julie Gralow

Visa Restrictions Threaten U.S. Health Care Workforce

Visa Restrictions

Hesham ElGhazaly: Egypt’s Voice and Commitment to Global Collaboration

Hesham ElGhazaly

OncoCalendar

Loading Events

« All Events

  • This event has passed.

VMAT and TomoTherapy TBI, TMI and TMLI by ESTRO

Jun 16 • 8:00 AM - Jun 17 • 5:00 PM
ESTRO

VMAT and TomoTherapy TBI, TMI and TMLI by ESTRO will be held from 16-17 June, 2025 at Utrecht, The Netherlands.

The Myeloablative Total Body Irradiation (TBI) symposium will feature international experts discussing the latest advancements in highly conformal radiotherapy techniques, such as VMAT and TomoTherapy, for haematopoietic stem cell transplantation (HSCT) conditioning. These techniques, including Total Marrow Irradiation (TMI) and Total Marrow and Lymphoid Irradiation (TMLI), aim to optimize treatment outcomes while minimizing toxicity by targeting specific areas like the bone marrow and lymphoid volume.

The symposium will include breakout sessions focused on technical and clinical aspects of VMAT and TomoTherapy planning and treatment. It is aimed at radiation oncologists, medical physicists, radiotherapy technologists, haematologists, and others interested in TBI, TMI, or TMLI.

Registration is open.

Venue

Utrecht
Utrecht, Netherlands + Google Map